Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol in Vasospastic Angina
NCT02087007Phase 3Completed
- Sponsor
- Otsuka Holdings
- Start
- Nov 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cilostazol in vasospastic angina (VSA), sponsored by Otsuka Holdings. Started Nov 2013; status: completed.
02
Drugs
cilostazol
03
Conditions
vasospastic angina (VSA)
Beyond the preview
Go deeper on NCT02087007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02087007.